Search:
   

Thursday, April 27, 2017

Equity Trader Alert #2017 - 90
Mast Therapeutics, Inc. (MSTX) and Savara Inc. to Merge and Begin Listing on Nasdaq on Friday, April 28, 2017

Category:

  • Industry Announcement

Markets Impacted:

Contact Information:

Resources:

Mast Therapeutics, Inc. (NYSE MKT: MSTX) and Savara Inc. have complete a merger today, Thursday, April 27, 2017. Following the merger, Mast Therapeutics, Inc. will have a corporate name and CUSIP change, undergo a 1-70 reverse stock split, and will begin trading on Nasdaq under the ticker symbol SVRA. Mast Therapeutics, Inc. will continue to be traded on NYSE MKT through the close of business today, Thursday, April 27, 2017. The details are as follows:

Current Company Name: Mast Therapeutics, Inc.
Issue: Common Stock
Current CUSIP: 576314108
Current Symbol: MSTX
New Company Name: Savara Inc.
New CUSIP: 805111101
New Symbol: SVRA
Ratio of Reverse Split: 1 for 70
Marketplace Effective Date: April 28, 2017

For information regarding this announcement, contact Nasdaq Corporate Data Operations at +1 877 308 0523.

If you would like to register as a market maker in SVRA, contact Nasdaq Trading Services at +1 212 231 5100.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Please follow Nasdaq on Facebook RSS and Twitter.

Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,900 total listings with a market value of approximately $13 trillion. To learn more, visit: business.nasdaq.com.

View NASDAQTrader.com Mobile